Concomitant beta-blocker use is associated with a reduced rate of remission in patients with rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs: a post hoc multicohort analysis

BACKGROUND: Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease associated with increased risk of cardiovascular disease (CVD). Treatment for CVD may involve pharmacological agents that antagonise beta adrenergic receptors. These receptors may play an important role in immunology,...

Descripción completa

Detalles Bibliográficos
Autores principales: Abuhelwa, Ahmad Y., Foster, David J. R., Manning-Bennett, Arkady, Sorich, Michael J., Proudman, Susanna, Wiese, Michael D., Hopkins, Ashley M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047969/
https://www.ncbi.nlm.nih.gov/pubmed/33912249
http://dx.doi.org/10.1177/1759720X211009020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047969/
https://www.ncbi.nlm.nih.gov/pubmed/33912249
http://dx.doi.org/10.1177/1759720X211009020

Ejemplares similares